Trial Profile
Expanded access study of Bryostatin-1
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 27 Oct 2021
Price :
$35
*
At a glance
- Drugs Bryostatin-1 (Primary)
- Indications Alzheimer's disease
- Focus Expanded access; Therapeutic Use
- 01 Feb 2017 New trial record